Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting Solutions

Hom, Milton M., OD, FAAO

Status

Unknown

Conditions

Contact Lens Solution Toxicity

Treatments

Other: OptiFree PureMoist

Other: RevitaLens

Study type

Interventional

Funder types

Industry

Identifiers

NCT01847105

12-GHS Comfort Study

Details and patient eligibility

About

Tolerability is compared between two Multi-purpose disinfecting solutions (MPDS).

Full description

According to recent surveys of contact lens fitters, the most prescribed treatments for contact lens dryness are: more frequent replacement schedule (24%), refit into different material (23%), rewetting drops (21%) and change care system (15%). Changing care systems has been a standard treatment for CL discomfort for many years. In the same survey, 30% of practitioners felt there is absolutely no difference among solutions with respect to reducing dryness and discomfort.

The investigators set out to compare the clinical performance of these two solutions: AMO's RevitaLens and Alcon's Opti-Free PureMoist.

Enrollment

54 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Between the ages of 18 and over inclusive.
Males or females
Patient is in generally good & stable overall health.
Patient likely to comply with study guidelines & study visits.
Informed consent signed.
Are willing/able to return for all required study visits.
Are willing/able to follow instructions from the study investigator and his/her staff.
Have signed informed consent approved by Institutional Review Board or Independent Ethics Committee.

Exclusion criteria

Corneal refractive surgery within 6 months of this study.
Intra-ocular surgery within 6 months or ocular laser surgery within 6 months.
Ocular pathology (includes glaucoma and cataract), which could impact results and/or place patient at risk.